Clientele:
Pharmaceuticals
The commercialization of pharmaceutical products is an extraordinary process. No industry has a longer, more expensive development timeframe combined with a short patent protected window in which to recoup its enormous investment.
If a drug has the fortitude to be one of the few to survive the scientific and regulatory gauntlet, it enters an intensely competitive and fluid marketplace in which three key decision makers are involved in every purchase: the patient who has the condition, the physician who selects the appropriate therapy, and the payor who determines access to reimbursement. A successful product value maximization strategy requires comprehensive, timely information about these three independent entities, as well as the relationships that bring them together.
This is the focus and passion of Putnam Associates. We have been serving the most respected pharmaceutical companies and their products for nearly 20 years. We proudly work with 9 of the top 20 and 4 of the top 5 global pharmaceutical leaders. The range of therapies that our activities address is from blockbuster drugs that realize billions in revenue annually to specialty pharmaceuticals that earn $100 million over their lifetime.